acetylglucosamine has been researched along with Bile Duct Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Phoomak, C; Saengboonmee, C; Sawanyawisuth, K; Seubwai, W; Silsirivanit, A; Vaeteewoottacharn, K; Wongkham, C; Wongkham, S | 1 |
1 other study(ies) available for acetylglucosamine and Bile Duct Cancer
Article | Year |
---|---|
High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation.
Topics: Acetylglucosamine; Acylation; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cholangiocarcinoma; Dose-Response Relationship, Drug; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Humans; N-Acetylglucosaminyltransferases; Neoplasm Metastasis; Nitrogenous Group Transferases; Vimentin | 2017 |